购物车
- 全部删除
- 您的购物车当前为空
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 | |
100 mg | 询价 | 10-14周 |
产品描述 | SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. |
靶点活性 | SGLT1/ SGLT2 (human):29nM/20 nM |
分子量 | 669.85 |
分子式 | C37H55N3O8 |
CAS No. | 1240305-17-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.